1

Michael J. Masamitsu, Pharm. D. Florence, Massachusetts 01062

mjm1234@comcast.net PROFESSIONAL PROFILE Self-motivated, accomplished Health Care Professional with over 30 years of experience in clinical pharmacy practice, teaching and education, health economics and outcomes research, corporate medical affairs, and management. This includes 19+ years of experience in the Pharmaceutical Industry with 11+ in Biotechnology and 8+ years of experience in direct line management. Extensive experience in the creation of scientific presentations specifically tailored to a broad range of audiences including, Major Medical Congresses, Tier-1 and Tier-2 Thought leaders, Fieldbased Medical Liaisons, pharmacists, nurses, and Managed Care Audiences. Actively participated in gap analysis and publication planning. A demonstrated record of leadership, innovation, team building, strategic planning, and new program development within dynamic and evolving environments with professional experience in the following areas: Therapeutic Areas Cardiology Hypercholesterolemia Adult Critical Care Medicine Infectious Disease Nephrology Hematology Oncology Rheumatology Dermatology Diabetes Osteoporosis Functional Areas Identifying and cultivating relationships with KOLs Managed Care Markets including National and regional commercial accounts, Medicaid, and Medicare Health Services Research and Pharmacoeconomics Medical Information, Medical Communications Assisted in Development of AMCP Product Dossiers including Budget Impact Models MSL, Corporate Account, and Sales Training Resource development for field RML use Content Development for Major Medical Symposia Advisory boards and Market research panels Gap analysis and Publication Planning

CURRICULUM VITAE

~ PROFESSIONAL Experience ~ AMGEN

SENIOR REGIONAL MEDICAL LIAISON

Health Outcomes and Pharmacoeconomics (HOPE) Scientific Affairs, Amgen North America (August 2003 Present) Managed Care Markets Identified and cultivated and relationships with key Managed Care Decision Makers and Health Outcomes thought leaders, Provided medical information on Amgen products to Managed Care, Medicaid, and Medicare Organizations Therapeutic Areas supported: Oncology, Nephrology/CKD, Rheumatology, Dermatology, Hematology, Osteoporosis Provided Medical, Health-outcomes, and Pharmacoeconomic information to Payors in response to unsolicited inquiries on all Amgen products Health Services Research Identified opportunities to support Health Services Research initiatives at Managed Care Accounts Recommended potential partners for Amgen initiated Health Outcomes research protocols & Advisory Boards Identified potential Investigator Initiated Research opportunities

2
Pipeline and Resource Development Product Lead OncoVex and Blinatumomab (2011-current) o Identification and development of HOPE Training resources for disease state (malignant melanoma, ALL) and current therapeutic options. o Pre-launch planning Training and Development for HOPE RMLs Advise and participate in AMCP Dossier development with Medical Information Advise and Develop Slide decks and other field resources with Medical Communications Collaborate with Global Health Economics in development of Disease-state and Budget Impact Models specific to Managed Care and Managed Markets Product Lead Enbrel (2008 2011) o Advised RAV Team [Reimbursement, Access, and Value] on Publication Plan, research and Life cycle management strategies. o Advised GHE, MedCom on the content, development, and prioritization of HOPE resources o Submited semi-annual POA for Enbrel RA, PsO to HOPE Senior Leadership Team o Conducedt routine meetings with GHE, Medical Communications, Scientific Affairs Training o Planned and Coordinated HOPE and Global Health Economics activities at major congresses (ASH, ASCO, ACR) o Provided editorial input on AMCP Dossier to Med Info and GHE including Budget Impact Models Past Team/Product Lead appointments - Aranesp, Neupogen/Neulasta, Kepivance, Vectibix, Nplate, VA/DOD Resource Development Developed and championed appropriate mechanisms for early stage RML input into resource development with Global Health Economics, Medical Information and Medical Communications Management Assisted in the management of the group as requested Participated in interviewing, assessing, and hiring of new RMLs Conducted new hire and ongoing therapeutic training of Corporate Account Managers and HOPE RMLs and other RML groups

ASSOCIATE DIRECTOR FIELD DEVELOPMENT AND TRAINING

Inflammation Medical Affairs, Amgen (September 2002 August 2003) Management Primarily responsible for integration of the two field Medical Liaison groups after acquisition of Immunex Actively participated in the overall management of the RML group. Conducted field assessment and training as required including interviewing candidates, new hire training, mentoring, coaching and counseling. Planned and implemented a continuous training model Resource Development Developed and championed appropriate mechanisms for early stage RML input into resource development with Medical Information and Medical Communications Developed RML resources that support successful execution of the POA on a yearly basis. Training and Development Developed and implemented an On-boarding training processes o Disease State and product specific training On-going Training and Development o Developing Indications for current products o Pre-launch and post launch training for new products and indications o Competitive products o Personal Skills Development RML University/ RML EDGE o Assisted in the Development of an overall strategy and design for RML University [AKA EDGE] o Developed modular training components for the Inflammation, Oncology, and Anemia RML groups

3
Field Based RML Training Planned and coordinated the field based component new hire training Assisted in coordination and planning of Thousand Oaks based component of new hire training Planned and developed a program for on-going training of field personnel Medical Advocacy and Opinion Leader Development Developed and cultivated strong professional relationships with key medical thought leaders Provided current slides/data reviews for key OL/Speakers/Consultants as requested Supported local speaker development and evaluation Provided focused pre-launch support for new products Medical Education and Research Provided medical education and research grants Provided a conduit for Opinion Leader initiated research protocols into the company Identified opportunities for collaboration and/or in-licensing of Amgen Products

REGIONAL MEDICAL LIAISON

Rheumatology (Inflammation) Medical Affairs Amgen North America (February 2002 September 2002) Medical Advocacy and Opinion Leader Development Developed and cultivated strong professional relationships with key medical thought leaders Provided current slides/data reviews for key OL/Speakers/Consultants Fluently conveyed complex scientific ideas in an articulate, persuasive manner Supported local speaker development and evaluation. Provided focused pre-launch support for new indications and products Medical Education and Research Evaluated potential medical education and research grants Managed and strategically allocated medical education grants Provided a conduit for Opinion Leader initiated research protocols into the company Research and Grant Administration Acted as the principal contact between OL and medical affairs on investigator initiated research Provided medical education and research grants to targeted OLs/Medical Groups Evaluated unsolicited research requests based on scientific and business merit Managed and strategically allocate product-specific medical education grants Identified and assessed Investigator Initiated research proposals

BRISTOL-MYERS, SQUIBB

REGION ASSOCIATE DIRECTOR MEDICAL SCIENCE DEPARTMENT

Bristol-Myers, Squibb - New England (1999 December 31, 2001) Management Managed and Mentored a team of 6-10 Medical Science Managers and Medical Service Associates in New England and Upstate New York. o Interviewing and Hiring o Professional Growth and Career Development o Therapeutic and Product Training o Coaching and Counseling o Presentation and Moderator Skills Training o Performance Evaluation o Business Orientation and Planning o Mentoring Directed the support of field-based medical education and research initiatives Integrated Strategic Business Planning of the Medical Science team with field territory, managed care, and hospital sales personnel. Corporate Continuing Medical Education Developed and oversaw Pravachol Symposia held at the 2001 American Heart Association meeting

ASSOCIATE DIRECTOR MEDICAL EDUCATION CARDIOVASCULAR DRUGS

Medical Affairs Department Bristol-Myers, Squibb - Plainsboro, New Jersey (1997 1999) Cultivated and developed professional relationships with Global Tier-1 opinion leaders in preventive cardiology and cardiovascular medicine Conducted Gap analysis and Publication Planning Developed, and conducted symposia for major medical meetings o Major National and International Symposia (AHA, ACC, ADA, ASHP, ESC) o Advisory Boards o Speaker Training Meetings o Regional and Local Events Oversaw vendor-related activities for Pravachol Medical Education programs (symposia, Ad-boards, etc) Supported training of field-based personnel (Sales, Medical Science Managers) on Pravachol and Atherosclerosis. Participated in National Pravachol Business Planning with Marketing, Legal/Regulatory, & Medical Liaisons Assisted in establishment of ASHP- Certified Pharmacy Fellowship Position in the Cardiovascular Medical Operations Department

NATIONAL PRAVACHOL LIAISON - MEDICAL SCIENCE DEPARTMENT

Bristol-Myers, Squibb (1995 1997) Acted as the primary liaison between the Medical Science, Medical Operations, and Pravachol marketing. Developed content for PowerPoint slide and presentations utilized by all MSMs. Interfaced with Marketing and legal/regulatory Departments. Participated and conducted market research programs.

SENIOR MEDICAL SCIENCE MANAGER

Bristol-Myers, Squibb - New England (1996 1997) Therapeutic Areas: Hyperlipidemia, Infectious Disease, CNS Depression, Diabetes, Hypertension Assisted in the management of the group Recognized for excelling in all aspects of MSM job performance. Acted as a role model for other Medical Science Managers in all aspects of the position Provided training and mentoring to field-based MSMs Assumed personnel and/or project management as requested by the Area Associate Director

MEDICAL SCIENCE MANAGER

Bristol-Myers, Squibb - New England (1994 1996) Medical Education and Customer Service Fluently conveyed complex scientific ideas in an articulate, persuasive manner to any audience. Demonstrated principled leadership and sound business ethics. Supported key Managed Health Care customers and academic hospital institutions with medical education and research grants. Opinion Leader Development Developed and cultivate strong professional relationships with key medical thought leaders Provided current slides/data reviews for key OL/Speakers/Consultants Supported local speaker development and evaluation. Provided focused pre-launch support for new products Research and Grant Administration Provided medical education and research grants Evaluated unsolicited research requests based on scientific merit Managed and allocated product-specific medical education grants Identified and assess Investigator Initiated research proposals.

5
ADJUNCT ASSISTANT PROFESSOR OF CLINICAL PHARMACY

Massachusetts College of Pharmacy and Allied Health Sciences - Boston, Massachusetts 1988 - 1994 Provided Therapeutics Lectures and Preceptorship to Students and Faculty Established a Clinical Pharmacy Rotation site (Baystate Medical Center) Conducted daily lectures, case presentations, and guidance to Pharmacy students Established a Full-time Faculty Position in Medical ICU (1994)

DIRECTOR CLINICAL PHARMACY SERVICES, Associate Director of Pharmacy

Baystate Medical Center - Springfield, Massachusetts (1988 1994) Administrative and Management: Had primary responsibility for Formulary Management Developed and Direct a comprehensive Clinical Pharmacy Service (6 FTEs) Managed distributional pharmacy services Established and directed Patient Care Rounds by Clinical Pharmacy Staff ICU, Neonatal & Peds ICU, Oncology Clinic, Infectious Disease, Long-Term Care Unit Oversaw Operation of Satellite Pharmacies Adult ICU, Neonatal ICU, OR, ER Established, Develop and Direct an Investigational Drug Service Documented cost savings based upon clinical interventions and formulary management Established and Promote the adoption of rational, cost-effective drug therapies Developed appropriate drug use and DUR criteria for high cost therapies Established a mechanism for the assessment for new biotech drugs and pharmaceutical-based technologies Planned, coordinated, and implemented the Drug Usage Evaluation Program for Baystate Medical Center Developed budget and utilization information to improve operations and justify expansion of Clinical Services Directed and managed the strategic and day-to-day operations of the Clinical Pharmacy Department (7FTEs) Assisted in the direction and day-to-day management of the pharmacy department (~27-33 FTEs) Conducted hiring and performance evaluation of all departmental personnel. Performed Coaching, Counseling, Mentoring, and discipline of employees Designed a new system for Adverse Drug Reaction reporting. Developed a Quality Assurance program for Clinical Pharmacy Services. Coordinated, monitor, and control drug detailing activities of Pharmaceutical Industry Representatives. Established and oversee the operation of a Technology Assessment Committee to analyze emerging therapies and their potential impact on patient outcomes and hospital operations Clinical and Teaching: Participated in Daily Patient Care rounds with Attending Staff and Medical / Surgical Residents Adult ICU Developed and Directed Clinical Pharmacy Rotation for 5th year Pharmacy Students Developed and Directed continuing education programs for non-clinical staff Baystate Medical Center Committee Work Pharmacy and Therapeutics Committee (Secretary) Biotechnology Assessment Committee (Secretary) Medical Research Committee Transfusion Committee Nutritional Support Committee (Secretary) Pharmaceutical Service Rep. Committee (Secretary) Committee on Infections Medical Education AdvisoryCommittee Drug Usage Evaluation Committee P&T Committee Shriner's Hospital (Secretary) American Healthcare Systems Pharmacy Advisory Committee (Group Purchasing Organization)

Major Initiatives and New Program Development: Biotechnology Assessment Committee (1994) Mass College of Pharmacy ICU Position (1994) D.U.E. Clinical Pharmacist (1994) Pediatric Clinical Pharmacy Services (1993) Oncoscint Drug Use Criteria (1993) Biotechnology Assessment Committee (1992) ICU & PICU Clinical Pharmacy Services (1992) Formulary Optimization of H2 Blockers (1992) Professional Development Program (1992) NICU Satellite Pharmacy (1992) OR Satellite Pharmacy (1991) Investigational Drug Service (1991)

Limitation on TPA use Drug Use Criteria (1991) Nutritional Support Committee (1991) Electronic order-entry to prime vendor (1990) Hospital wide Unit Dose Drug Delivery (1990) Formulary Optimization of anti-infectives (1988 1994) Adverse Drug Reaction Reporting System (1990) Narcotic control system for Anesthesiology (1989) Pharmaceutical Service Council (1987) ICU Satellite Pharmacy (1988)

Massachusetts Medicaid Drug Utilization Program - Founding Board Member (1991 1994) Analyzed and assessed medication review and feedback of drug utilization patterns for Massachusetts Medicaid patients Conducted analysis, assessment, and review of physician drug prescribing patterns Planned and executed Medical Education Initiatives for the State of Massachusetts on rational drug therapies based upon above analyses Conducted Cost-effectiveness analysis of educational interventions TARGET DRUG PROJECT ADMINISTRATOR Baystate Medical Center - Springfield, Massachusetts (1987 - 1988) Developed a basis upon which Clinical Pharmacy Services could be cost-justified through the implementation of a Target Drug Monitoring Program. Annualized cost-avoidance estimates exceeded $550,000. PUBLICATIONS REVIEWER FOR PHARMACOTHERAPY (1987-1984)

~EDUCATION AND PROFESSIONAL TRAINING ~

CLINICAL PHARMACY RESIDENCY PROGRAM University of Illinois - Chicago, Illinois 1982 - 1983; Chief Resident [left early] DOCTOR OF PHARMACY 1982: University of Southern California - Los Angeles, California BACHELOR OF ARTS, Bacteriology 1974: UCLA - Graduated Magna cum Laude

(Updated 05/13)